CCR5 and inflammatory bowel disease: The recognition that neutrophil subsets, including CCR5+ pro-NETotic cells, EANs, and N1-3 states, share NET formation as a convergent effector pathway has driven interest in therapies that directly modulate NETosis in IBD.